Table 1.
Patient demographic and clinical characteristics.
| Clinicopathological Parameters | RL1 | RL2 |
|---|---|---|
| n = 100 | n = 82 | |
| Mean age at diagnosis (range) | 56 (25–84) years | 56 (25–84) years |
| Histology | ||
| High-grade serous | 83 (83%) | 69 (84.1%) |
| Low-grade serous | 4 (4%) | 2 (2.4%) |
| Endometrioid G1 | 3 (3%) | 3 (3.7%) |
| Endometrioid G2 | 4 (4%) | 3 (3.7%) |
| Endometrioid G3 | 0 | 0 |
| Clear cells | 4 (4%) | 3 (3.7%) |
| Seromucinous | 1 (1%) | 1 (1.2%) |
| Carcinosarcoma | 1 (1%) | 1 (1.2%) |
| FIGO Stage | ||
| I | 17 (17%) | 15 (18.3%) |
| II | 9 (9%) | 6 (7.3%) |
| III | 39 (39%) | 32 (39%) |
| IV | 21 (21%) | 17 (20.7%) |
| NA | 14 (14%) | 12 (14.6%) |
| gBRCA | ||
| wt-BRCA | 70 (70%) | 58 (70.7%) |
| VUS-BRCA | 13 (13%) | 10 (12.2%) |
| mt-BRCA | 16 (16%) | 13 (15.9%) |
| NA | 1 (1%) | 1 (1.2%) |
NA: not available; gBRCA: germline BRCA status; wt: wild type; VUS: variant of unknown significance; mt: mutated; RL: reference laboratory.